Verona Pharma plc
VRNA2025/10/7 下市- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc 已在 2025/10/7 下市;內部人最後一份 Form 4 在 2025/10/8 申報;2025 年第 3 季末有 243 家機構在 13F 申報持有,市值合計 $85.7 億;杜肯家族辦公室和索羅斯基金管理兩位大師持有。
持有 VRNA 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Verona Pharma plc 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 13G | 6.00%股數 2,765 萬 | 新申報 | 2025/10/171 份 | 2025/10/17 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。
13D 與 13G 申報
Verona Pharma plc 的 42 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。
| 申報時間(美東) | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2025/11/1416:27 ET | Pentwater Capital Management LP等 2 位 | 13G | 0.00%股數 0 | 新申報低於 5% | 2025/9/30 | SEC |
| 2025/11/1416:00 ET | Perceptive Advisors LLC等 3 位 | 13G/A | 0.00%股數 0 | −6.40 個百分點原本 6.40%低於 5% | 2025/9/30 | SEC |
| 2025/11/1410:24 ET | Janus Henderson Group PLC | 13G/A | 1.20%股數 101.1 萬 | −6.00 個百分點原本 7.20%低於 5% | 2025/9/30 | SEC |
| 2025/10/1712:45 ET | BlackRock Portfolio Management LLC | 13G | 6.00%股數 2,765 萬 | 新申報 | 2025/9/30 | SEC |
| 2025/8/1418:14 ET | Ra Capital Management, L.P.等 4 位 | 13G/A | 0.70%股數 59.4 萬 | −6.40 個百分點原本 7.10%低於 5% | 2025/6/30 | SEC |
| 2025/8/1416:15 ET | Perceptive Advisors LLC等 3 位 | 13G/A | 6.40%股數 550.8 萬 | – | 2025/6/30 | SEC |
| 2025/8/1411:27 ET | Janus Henderson Group PLC | 13G/A | 7.20%股數 613.4 萬 | +0.70 個百分點原本 6.50% | 2025/6/30 | SEC |
| 2025/5/1516:49 ET | Ra Capital Management, L.P.等 4 位 | 13G/A | 7.10%股數 601.1 萬 | −1.80 個百分點原本 8.90% | 2025/3/31 | SEC |
| 2025/5/1411:47 ET | Janus Henderson Group PLC | 13G | 6.50%股數 553.9 萬 | 新申報 | 2025/3/31 | SEC |
| 2025/2/1418:43 ET | Ra Capital Management, L.P.等 4 位 | 13G/A | 8.90%股數 777.8 萬 | – | 2024/12/31 | SEC |
| 2025/2/1416:15 ET | Maverick Capital Ltd等 3 位大師Maverick 資本 | 13G/A | 3.80%股數 2,503 萬 | –低於 5% | 2024/12/31 | SEC |
| 2025/1/2120:33 ET | Growth Equity Opportunities Fund IV, LLC等 17 位 | 13D/A | 4.99%股數 3,268 萬 | –低於 5% | 2025/1/16 | SEC |
| 2024/11/14 | Perceptive Advisors LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/11/14 | Maverick Capital Ltd大師Maverick 資本 | 13G舊制 | – | 新申報 | – | SEC |
| 2024/11/14 | Deep Track Capital, LP | 13G/A舊制 | – | – | – | SEC |
| 2024/11/14 | Ra Capital Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2024/11/13 | Vivo Ventures VII, LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/11/12 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/8/28 | Growth Equity Opportunities Fund IV, LLC | 13D/A舊制 | – | – | – | SEC |
| 2024/7/29 | Perceptive Advisors LLC | 13G舊制 | – | – | – | SEC |
| 2024/7/12 | Deep Track Capital, LP | 13G舊制 | – | 新申報 | – | SEC |
| 2024/2/14 | Perceptive Advisors LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/2/14 | Ra Capital Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2024/2/9 | FMR LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2024/2/8 | Wellington Management Group LLP | 13G舊制 | – | – | – | SEC |
| 2023/5/16 | OrbiMed Advisors LLC | 13D/A舊制 | – | – | – | SEC |
| 2023/4/25 | Access Industries Holdings LLC | 13G/A舊制 | – | – | – | SEC |
| 2023/4/20 | Perceptive Advisors LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2023/2/14 | Vivo Ventures VII, LLC | 13G/A舊制 | – | – | – | SEC |
| 2023/2/14 | Ra Capital Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2023/2/9 | Access Industries Holdings LLC | 13G/A舊制 | – | – | – | SEC |
| 2023/2/6 | Wellington Management Group LLP | 13G/A舊制 | – | – | – | SEC |
| 2022/12/27 | OrbiMed Advisors LLC | 13D/A舊制 | – | – | – | SEC |
| 2022/9/7 | Growth Equity Opportunities Fund IV, LLC | 13D/A舊制 | – | – | – | SEC |
| 2022/8/12 | OrbiMed Advisors LLC | 13D/A舊制 | – | – | – | SEC |
| 2022/8/11 | Abingworth LLP | 13D/A舊制 | – | – | – | SEC |
| 2022/8/10 | Access Industries Holdings LLC | 13G/A舊制 | – | – | – | SEC |
| 2022/2/14 | Ra Capital Management, L.P. | 13G/A舊制 | – | – | – | SEC |
| 2022/2/11 | Vivo Ventures VI, LLC | 13G/A舊制 | – | – | – | SEC |
| 2022/2/4 | Wellington Management Group LLP | 13G舊制 | – | 新申報 | – | SEC |
| 2021/2/16 | Ra Capital Management, L.P. | 13G舊制 | – | 新申報 | – | SEC |
| 2021/2/5 | Novo Holdings A/S | 13G/A舊制 | – | – | – | SEC |
Form 144:內部人預計賣出
高階主管、董事與其他關係人預計賣出 Verona Pharma plc 股票的 29 份通知,由新到舊。
| 申報時間(美東) | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2025/6/1116:27 ET | David Zaccardelli董事 · 高階主管 | 5.00 萬 | $433.9 萬 | 2025/6/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/6/1116:26 ET | Mark Hahn高階主管 | 5.00 萬 | $433.9 萬 | 2025/6/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/2716:33 ET | David Zaccardelli董事 · 高階主管 | 5.00 萬 | $375.3 萬 | 2025/5/2710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/2716:31 ET | Mark Hahn高階主管 | 5.00 萬 | $375.3 萬 | 2025/5/2710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/2016:30 ET | Vikas Sinha董事 | 2.00 萬 | $145.2 萬 | 2025/5/2010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/1516:25 ET | Andrew Fisher高階主管 | 3.00 萬 | $201.7 萬 | 2025/5/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/1416:32 ET | Christina Ackermann董事 | 5,000 | $33.8 萬 | 2025/5/1410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/616:33 ET | Kathleen Rickard高階主管 | 1.44 萬 | $103.8 萬 | 2025/5/610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/216:24 ET | Mark Hahn高階主管 | 5.00 萬 | $361.3 萬 | 2025/5/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/216:24 ET | David Zaccardelli董事 · 高階主管 | 5.00 萬 | $361.3 萬 | 2025/5/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/4/2916:21 ET | Vikas Sinha董事 | 2.00 萬 | $137.7 萬 | 2025/4/2910b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/3/1216:23 ET | Kathleen Rickard高階主管 | 9,908 | $62.1 萬 | 2025/3/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/11/2516:42 ET | Kathleen A Rickard高階主管 | 3.00 萬 | $117.6 萬 | 2024/11/25 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/11/1207:55 ET | Mark Hahn高階主管 | 12.5 萬 | $482.3 萬 | 2024/11/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/11/1207:55 ET | David Zaccardelli董事 · 高階主管 | 12.5 萬 | $482.3 萬 | 2024/11/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/10/1816:20 ET | Mark Hahn高階主管 | 10.0 萬 | $346.6 萬 | 2024/10/1810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/10/1816:20 ET | David Zaccardelli董事 · 高階主管 | 10.0 萬 | $346.6 萬 | 2024/10/1810b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/9/1116:22 ET | Mark Hahn高階主管 | 7.50 萬 | $210.3 萬 | 2024/9/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/9/1116:22 ET | David Zaccardelli董事 · 高階主管 | 7.50 萬 | $210.3 萬 | 2024/9/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/8/1216:20 ET | David Zaccardelli高階主管 | 5.00 萬 | $113.1 萬 | 2024/8/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/8/1216:20 ET | Mark Hahn高階主管 | 5.00 萬 | $113.1 萬 | 2024/8/1210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/3/1219:45 ET | Rishi Gupta前董事 | 5.62 萬 | $89.4 萬 | 2024/3/12 | Morgan Stanley Smith Barney | SEC |
| 2024/3/420:15 ET | OrbiMed Private Investments VI, LP股東 | 100.0 萬 | $1,816 萬 | 2024/3/4 | Themis Trading LLC | SEC |
| 2024/2/516:19 ET | Kathleen Rickard高階主管 | 9,062 | $16.6 萬 | 2024/2/510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/11/316:25 ET | Kathleen Rickard高階主管 | 7,344 | $11.0 萬 | 2023/11/310b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
只列最新的 25 份。看 VRNA 近 12 個月的全部通知